There are numerous ways for makers of pricey brand-name drugs to delay the release of generic copies and hold on to the market for even a few months longer. They could make slight changes to the doses or even go so far as to buy a company that supplies a needed ingredient. But one pharmaceutical company is taking a new approach to putting off the release of generic versions — etching an additional score into the pill’s surface. [More]

Reddit user TheKarateKid says he emailed a major drug company asking why their $500 version of a $10 generic is worth the $490 markup. The drug company rep accidentally emailed the customer back this message intended for her colleague. [More]